Astrocyte Neuroprotection and Dehydroepiandrosterone

Vitam Horm. 2018:108:175-203. doi: 10.1016/bs.vh.2018.01.004. Epub 2018 Feb 19.

Abstract

Dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) are the most abundant steroid hormones in the systemic circulation of humans. Due to their abundance and reduced production during aging, these hormones have been suggested to play a role in many aspects of health and have been used as drugs for a multiple range of therapeutic actions, including hormonal replacement and the improvement of aging-related diseases. In addition, several studies have shown that DHEA and DHEAS are neuroprotective under different experimental conditions, including models of ischemia, traumatic brain injury, spinal cord injury, glutamate excitotoxicity, and neurodegenerative diseases. Since astrocytes are responsible for the maintenance of neural tissue homeostasis and the control of neuronal energy supply, changes in astrocytic function have been associated with neuronal damage and the progression of different pathologies. Therefore, the aim of this chapter is to discuss the neuroprotective effects of DHEA against different types of brain and spinal cord injuries and how the modulation of astrocytic function by DHEA could represent an interesting therapeutic approach for the treatment of these conditions.

Keywords: DHEA; Neurodegenerative diseases; Neuronal death; Spinal cord injury; Steroids; Stroke; Traumatic brain injury.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Astrocytes / physiology*
  • Brain Injuries, Traumatic / metabolism
  • Dehydroepiandrosterone / metabolism*
  • Humans
  • Neurodegenerative Diseases / metabolism
  • Neuroprotection / physiology*
  • Spinal Cord Injuries / metabolism

Substances

  • Dehydroepiandrosterone